Evotec Wins Research Grant to Advance H3 Receptor Antagonist Programme into the Clinic

News   Apr 27, 2010

 
Evotec Wins Research Grant to Advance H3 Receptor Antagonist Programme into the Clinic
 
 
 

RELATED ARTICLES

Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization

News

Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..

READ MORE

Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological Aging

News

The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.

READ MORE

Researchers Find a Way to Separate Side Effects of Opioid Drugs Reducing Risk

News

Scientists have discovered a way to separate these two effects -- pain relief and breathing, opening a window of opportunity to make effective pain medications without the risk of respiratory failure.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE